Importantly, the IFN-γ-secreting cell population was significantly greater in mice treated with RdB/IL12/shVEGF than mice treated with RdB/IL12, indicating that downregulation of VEGF expression can function as a potent adjuvant for IL-12-mediated induction of Th1 immunity in the tumor milieu. Here, VEGFA is linked to neoplasm.